Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of EMPAGLINAZ-M 5/1000 vs JARDIANCE DUO 5 mg/1000 mg under fed conditions in healthy Thai adults
TCTR20241212002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of empagliflozin + linagliptin and empagliflozin + metformin (2 arms), sponsored by Bio-innova. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
empagliflozin + linagliptinempagliflozin + metformin
Beyond the preview
Go deeper on TCTR20241212002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241212002.